Steinbach et al. [21] found that the overexpression of PRAME was found in 62% (n = 31) of acute myeloid leukemia patients, and the rates of OS and DFS were higher than in patients with no or low expression (P < 0.05). Here, PRAME is linked to acute myeloid leukemia.